Entera Bio Ltd. Logo

Entera Bio Ltd.

Developing oral versions of injectable drugs for osteoporosis, hypoparathyroidism, and obesity.

ENTX | US

Overview

Corporate Details

ISIN(s):
IL0011429839
LEI:
Country:
United States of America
Address:
KIRYAT HADASSAH, MINRAV BUILDING, 9112002 JERUSALEM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Entera Bio Ltd. is a clinical-stage biopharmaceutical company specializing in the development of orally delivered large molecule and peptide therapeutics. The company's proprietary N-Tab™ technology platform enables the oral administration of drugs that are typically injectable by stabilizing the active ingredients in the gastrointestinal tract and enhancing absorption. Entera's primary focus is on therapies for significant unmet medical needs. Its clinical pipeline is led by EB613, an oral parathyroid hormone (PTH) tablet for postmenopausal women with osteoporosis, and EB612 for patients with hypoparathyroidism. The company is also developing oral treatments for obesity and rare malabsorption conditions like short bowel syndrome.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Entera Bio Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Entera Bio Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Entera Bio Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

WHANIN PHARM CO.,LTD Logo
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
South Korea
016580
Whitehawk Therapeutics, Inc. Logo
Develops advanced antibody-drug conjugates (ADCs) for difficult-to-treat cancers.
United States of America
WHWK
WooGeneB&GCO.,Ltd Logo
Manufactures veterinary medicines, vaccines, and supplements for livestock and aquatic animals.
South Korea
018620
X4 Pharmaceuticals, Inc Logo
Developing and commercializing novel therapies for rare diseases of the immune system.
United States of America
XFOR
XBiotech Inc. Logo
Develops therapeutic antibodies from natural human immunity for inflammatory diseases and oncology.
United States of America
XBIT
Xbrane Biopharma Logo
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden
XBRANE
Xencor Inc Logo
Engineering antibody & cytokine therapeutics for cancer and autoimmune diseases via its XmAb platform.
United States of America
XNCR
Xenon Pharmaceuticals Inc. Logo
A neuroscience biopharma developing novel therapeutics for epilepsy and depression.
United States of America
XENE
Xeris Biopharma Holdings, Inc. Logo
Develops ready-to-use injectable drugs for chronic, metabolic, and rare diseases.
United States of America
XERS
Xintela AB Logo
Develops stem cell therapies for osteoarthritis and venous leg ulcers using proprietary technology.
Sweden
XINT

Talk to a Data Expert

Have a question? We'll get back to you promptly.